Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 498,413 | 487,933 | 476,845 | 455,731 | 537,767 |
| Marketable Securities | 393,940 | 394,878 | 360,185 | 364,645 | 363,515 |
| Receivables | 75,880 | 69,761 | 63,094 | 63,009 | 63,659 |
| Inventories | 5,655 | 5,456 | 6,804 | 5,446 | 4,518 |
| TOTAL | $1,022,848 | $1,002,298 | $948,625 | $929,864 | $1,005,905 |
| Non-Current Assets | |||||
| PPE Net | 9,433 | 9,548 | 9,770 | 10,092 | 9,160 |
| Investments And Advances | 0 | 0 | 38,126 | 0 | 0 |
| Other Non-Current Assets | 70,219 | 70,541 | 31,487 | 69,550 | 69,573 |
| TOTAL | $79,652 | $80,089 | $79,383 | $79,642 | $78,733 |
| Total Assets | $1,102,500 | $1,082,387 | $1,028,008 | $1,009,506 | $1,084,638 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 48,207 |
| Accounts payable and accrued liabilities | 22,956 | 23,856 | 29,105 | 25,100 | 19,721 |
| Accrued Expenses | 144,937 | 143,785 | 118,341 | 185,534 | 197,224 |
| TOTAL | $170,353 | $170,078 | $149,163 | $212,181 | $266,249 |
| Non-Current Liabilities | |||||
| Long Term Debt | 392,587 | 392,060 | 391,530 | 391,013 | 390,488 |
| Deferred Revenues | 582 | 594 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 138,001 | 126,521 | 103,224 | 40,162 | 44,277 |
| TOTAL | $535,583 | $523,828 | $500,366 | $436,609 | $440,562 |
| Total Liabilities | $705,936 | $693,906 | $649,529 | $648,790 | $706,811 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,530 | 50,387 | 50,234 | 50,068 | 50,033 |
| Common Shares | 135 | 135 | 135 | 135 | 135 |
| Retained earnings | -801,215 | -801,038 | -790,738 | -795,761 | -771,990 |
| Other shareholders' equity | -30,005 | -26,613 | -33,089 | -33,762 | -31,172 |
| TOTAL | $396,564 | $388,481 | $378,479 | $360,716 | $377,827 |
| Total Liabilities And Equity | $1,102,500 | $1,082,387 | $1,028,008 | $1,009,506 | $1,084,638 |